LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Actinium Pharmaceuticals Inc

Fermé

1.81 8.38

Résumé

Variation du prix de l'action

24h

Actuel

Min

1.62

Max

1.84

Chiffres clés

By Trading Economics

Revenu

-9.3M

-16M

BPA

-0.51

Employés

31

EBITDA

-9.3M

-17M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+255.03% upside

Dividendes

By Dow Jones

Prochains Résultats

1 août 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

2.2M

51M

Ouverture précédente

-6.57

Clôture précédente

1.81

Actinium Pharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

5 juin 2025, 20:45 UTC

Résultats

Broadcom 2Q Sales Climb on Booming AI Demand

5 juin 2025, 23:45 UTC

Market Talk

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5 juin 2025, 23:44 UTC

Market Talk

Gold Edges Higher on Weak U.S. Data -- Market Talk

5 juin 2025, 23:30 UTC

Market Talk

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5 juin 2025, 21:32 UTC

Résultats

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 juin 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

5 juin 2025, 20:45 UTC

Résultats

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 juin 2025, 20:24 UTC

Résultats

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 juin 2025, 20:15 UTC

Résultats

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5 juin 2025, 20:15 UTC

Résultats

Broadcom 2Q Rev $15B >AVGO

5 juin 2025, 20:15 UTC

Résultats

Broadcom 2Q Net $4.97B >AVGO

5 juin 2025, 20:15 UTC

Résultats

Broadcom 2Q Adj EPS $1.58 >AVGO

5 juin 2025, 20:15 UTC

Résultats

Broadcom 2Q EPS $1.03 >AVGO

5 juin 2025, 20:15 UTC

Résultats

Broadcom Sees 3Q Rev $15.8B >AVGO

5 juin 2025, 20:11 UTC

Acquisitions, Fusions, Rachats

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5 juin 2025, 20:11 UTC

Acquisitions, Fusions, Rachats

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5 juin 2025, 20:11 UTC

Acquisitions, Fusions, Rachats

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5 juin 2025, 19:22 UTC

Market Talk

Oil Futures Resume Upward Moves -- Market Talk

5 juin 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5 juin 2025, 18:32 UTC

Market Talk

Gold Slips After Trump-Xi Call -- Market Talk

5 juin 2025, 18:26 UTC

Résultats

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5 juin 2025, 18:06 UTC

Market Talk

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5 juin 2025, 16:30 UTC

Acquisitions, Fusions, Rachats

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5 juin 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

5 juin 2025, 16:18 UTC

Market Talk

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5 juin 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

5 juin 2025, 16:12 UTC

Market Talk

Global Energy Roundup: Market Talk

5 juin 2025, 16:12 UTC

Market Talk

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5 juin 2025, 16:03 UTC

Market Talk

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5 juin 2025, 15:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Comparaison

Variation de prix

Actinium Pharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

255.03% hausse

Prévisions sur 12 Mois

Moyen 6 USD  255.03%

Haut 9 USD

Bas 4 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

3 ratings

3

Achat

0

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. Its Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). The company focuses on advancing its development for product candidate Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies. Its Iomab-ACT, a next generation conditioning candidate, is being developed for improving patient access and outcomes for curative cell and gene therapies. Further, the company's research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company holds approximately 235 patents and patent applications, including various patents related to the manufacture of the isotope Ac-225 in a cyclotron. The company is based in New York, New York.